Fortis Advisors’s Nu Skin NUS Stock Holding History

Fortis Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,713	Closed	-$147K	–	273
2020 Q1	$147K	Buy	+6,713	New	+$202K	0.1%	112
2018 Q4	–	Sell	-1,880	Closed	-$155K	–	320
2018 Q3	$155K	Hold	1,880	–	–	0.09%	97
2018 Q2	$147K	Hold	1,880	–	–	0.08%	102
2018 Q1	$139K	Hold	1,880	–	–	0.08%	94
2017 Q4	$128K	Buy	1,880 +134	+8%	+$8.67K	0.08%	108
2017 Q3	$107K	Buy	+1,746	New	+$107K	0.07%	113

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fortis Advisors's NUS Position: Q2 2020 in Review

Fortis Advisors sold out of Nu Skin (NUS) in Q2 2020, closing a stake of 6,713 shares — an estimated $147K sold.

Fortis Advisors first reported a position in NUS in Q3 2017 and held it in 6 quarters. The position peaked at $155K in Q3 2018. 226 funds tracked by Wall St. Rank hold NUS as of Q2 2020.

Fortis Advisors reported no remaining Nu Skin position as of Q2 2020 after selling out during the quarter.
Fortis Advisors sold 6,713 Nu Skin shares in Q2 2020, an estimated $147K.
Fortis Advisors first reported a position in Nu Skin in Q3 2017 and held it in 6 quarters.
Fortis Advisors's Nu Skin position peaked at $155K in Q3 2018.
226 funds tracked by Wall St. Rank held Nu Skin as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.